136 related articles for article (PubMed ID: 23226214)
1. Body mass index and serum proteomic profile in breast cancer and healthy women: a prospective study.
Garrisi VM; Tufaro A; Trerotoli P; Bongarzone I; Quaranta M; Ventrella V; Tommasi S; Giannelli G; Paradiso A
PLoS One; 2012; 7(11):e49631. PubMed ID: 23226214
[TBL] [Abstract][Full Text] [Related]
2. A new tumor biomarker, serum protein peak at 3,144 m/z, in patients with node-positive breast cancer.
Chen Z; Xu S; Su D; Liu W; Yang H; Xie S; Meng X; Lei L; Wang X
Clin Transl Oncol; 2015 Jun; 17(6):486-94. PubMed ID: 25511546
[TBL] [Abstract][Full Text] [Related]
3. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
[TBL] [Abstract][Full Text] [Related]
4. Primary study of lymph node metastasis-related serum biomarkers in breast cancer.
Wang L; Su D; Yan HJ; Xu JH; Zheng ZG; Hu YJ; Pan XD; Ding XW; Chen C; Chen B; Mao WM; Meng XL
Anat Rec (Hoboken); 2011 Nov; 294(11):1818-24. PubMed ID: 21964916
[TBL] [Abstract][Full Text] [Related]
5. Testosterone and biological characteristics of breast cancers in postmenopausal women.
Secreto G; Venturelli E; Meneghini E; Greco M; Ferraris C; Gion M; Zancan M; Fabricio AS; Berrino F; Cavalleri A; Micheli A
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2942-8. PubMed ID: 19843675
[TBL] [Abstract][Full Text] [Related]
6. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
[TBL] [Abstract][Full Text] [Related]
7. Impact of Body Mass Index on Clinical Axillary Nodal Assessment in Breast Cancer Patients.
McCartan D; Stempel M; Eaton A; Morrow M; Pilewskie M
Ann Surg Oncol; 2016 Oct; 23(10):3324-9. PubMed ID: 27338746
[TBL] [Abstract][Full Text] [Related]
8. Impact of the obesity on lymph node status in operable breast cancer patients.
Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Solak M; Turkoz FP; Arik Z; Esin E; Petekkaya I; Altundag K
J BUON; 2013; 18(4):824-30. PubMed ID: 24344004
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
10. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
Key TJ; Appleby PN; Reeves GK; Roddam A; Dorgan JF; Longcope C; Stanczyk FZ; Stephenson HE; Falk RT; Miller R; Schatzkin A; Allen DS; Fentiman IS; Key TJ; Wang DY; Dowsett M; Thomas HV; Hankinson SE; Toniolo P; Akhmedkhanov A; Koenig K; Shore RE; Zeleniuch-Jacquotte A; Berrino F; Muti P; Micheli A; Krogh V; Sieri S; Pala V; Venturelli E; Secreto G; Barrett-Connor E; Laughlin GA; Kabuto M; Akiba S; Stevens RG; Neriishi K; Land CE; Cauley JA; Kuller LH; Cummings SR; Helzlsouer KJ; Alberg AJ; Bush TL; Comstock GW; Gordon GB; Miller SR; Longcope C;
J Natl Cancer Inst; 2003 Aug; 95(16):1218-26. PubMed ID: 12928347
[TBL] [Abstract][Full Text] [Related]
11. Proteomic profile in familial breast cancer patients.
Garrisi VM; Tommasi S; Facchiano A; Bongarzone I; De Bortoli M; Cremona M; Cafagna V; Abbate I; Tufaro A; Quaranta M; Paradiso A
Clin Biochem; 2013 Feb; 46(3):259-65. PubMed ID: 23159292
[TBL] [Abstract][Full Text] [Related]
12. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
13. Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study.
Geczik AM; Falk RT; Xu X; Ansong D; Yarney J; Wiafe-Addai B; Edusei L; Dedey F; Vanderpuye V; Titiloye N; Adjei E; Aitpillah F; Osei-Bonsu E; Oppong J; Biritwum R; Nyarko K; Wiafe S; Awuah B; Clegg-Lamptey JN; Ahearn TU; Figueroa J; Garcia-Closas M; Brinton LA; Trabert B
Breast Cancer Res; 2022 Jan; 24(1):9. PubMed ID: 35081987
[TBL] [Abstract][Full Text] [Related]
14. Serum biomarker 3144 m/z for prognostic detection in Chinese postmenopausal breast cancer patients.
Gao Y; Xu S; Cao W; Chen Z; Wang X; Zou D
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C68-73. PubMed ID: 26323928
[TBL] [Abstract][Full Text] [Related]
15. The association between body mass index and immunohistochemical subtypes in breast cancer.
Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis.
Nakagawa T; Huang SK; Martinez SR; Tran AN; Elashoff D; Ye X; Turner RR; Giuliano AE; Hoon DS
Cancer Res; 2006 Dec; 66(24):11825-30. PubMed ID: 17178879
[TBL] [Abstract][Full Text] [Related]
17. Relationship of breast volume, obesity and central obesity with different prognostic factors of breast cancer.
Lubián López DM; Butrón Hinojo CA; Castillo Lara M; Sánchez-Prieto M; Sánchez-Borrego R; Mendoza Ladrón de Guevara N; González Mesa E
Sci Rep; 2021 Jan; 11(1):1872. PubMed ID: 33479372
[TBL] [Abstract][Full Text] [Related]
18. Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women.
Miyagawa Y; Miyake T; Yanai A; Murase K; Imamura M; Ichii S; Takatsuka Y; Ito T; Hirota S; Saito M; Kotoura Y; Miyauchi K; Fujimoto Y; Hatada T; Sasa M; Miyoshi Y
Breast Cancer; 2015 Jul; 22(4):399-405. PubMed ID: 24000037
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
[TBL] [Abstract][Full Text] [Related]
20. Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study.
Iyengar NM; Arthur R; Manson JE; Chlebowski RT; Kroenke CH; Peterson L; Cheng TD; Feliciano EC; Lane D; Luo J; Nassir R; Pan K; Wassertheil-Smoller S; Kamensky V; Rohan TE; Dannenberg AJ
JAMA Oncol; 2019 Feb; 5(2):155-163. PubMed ID: 30520976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
